Buscar
Recursion Pharmaceuticals Inc
RXRXAñadir a la lista de seguimiento
3.000USD
+0.030+1.02%
Cierre 07-29 16:00（ET）Cotizaciones retrasadas 15 min
1.58BCap. mercado
PérdidaP/E TTM
Más Datos de Recursion Pharmaceuticals Inc Compañía
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology and chemistry to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits, scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate silico hypotheses into validated insights and novel chemistry. Its clinical programs in oncology and rare diseases include REC-617, REC-1245, REC-3565 and REC-4539. Its REC-617 is an orally bioavailable, cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced solid tumors. Its REV102 program targets ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), an enzyme implicated in the pathogenesis of HPP.
Información de Recursion Pharmaceuticals Inc
Símbolo de cotizaciónRXRX
Nombre de la empresaRecursion Pharmaceuticals Inc
Fecha de salida a bolsaApr 16, 2021
Director ejecutivoKhan (Najat)
Número de empleados840
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 16
Dirección41S Rio Grande Street
CiudadSALT LAKE CITY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal84101
Teléfono13852690203
Sitio Webhttps://www.recursion.com/
Símbolo de cotizaciónRXRX
Fecha de salida a bolsaApr 16, 2021
Director ejecutivoKhan (Najat)
Ejecutivos de Recursion Pharmaceuticals Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Independent Director
Independent Director
3.32M
+0.11%
Mr. Ben R. Taylor
Mr. Ben R. Taylor
Chief Financial Officer, President of Recursion UK
Chief Financial Officer, President of Recursion UK
291.66K
-1.85%
Mr. Zavain Dar
Mr. Zavain Dar
Independent Director
Independent Director
240.76K
+2.12%
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
162.16K
+54.53%
Dr. Najat Khan, Ph.D.
Dr. Najat Khan, Ph.D.
President, Chief Executive Officer
President, Chief Executive Officer
152.72K
-15.44%
Ms. Elaine D. Sun
Ms. Elaine D. Sun
Independent Director
Independent Director
111.61K
+79.22%
Dr. Christopher Gibson, Ph.D.
Dr. Christopher Gibson, Ph.D.
Chairman of the Board
Chairman of the Board
17.94K
--
Mr. Zachary Bogue, J.D.
Mr. Zachary Bogue, J.D.
Independent Director
Independent Director
9.38K
--
Dr. Blake Borgeson, Ph.D.
Dr. Blake Borgeson, Ph.D.
Independent Director
Independent Director
--
--
Dr. Franziska Michor, Ph.D.
Dr. Franziska Michor, Ph.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Independent Director
Independent Director
3.32M
+0.11%
Mr. Ben R. Taylor
Mr. Ben R. Taylor
Chief Financial Officer, President of Recursion UK
Chief Financial Officer, President of Recursion UK
291.66K
-1.85%
Mr. Zavain Dar
Mr. Zavain Dar
Independent Director
Independent Director
240.76K
+2.12%
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
162.16K
+54.53%
Dr. Najat Khan, Ph.D.
Dr. Najat Khan, Ph.D.
President, Chief Executive Officer
President, Chief Executive Officer
152.72K
-15.44%
Ms. Elaine D. Sun
Ms. Elaine D. Sun
Independent Director
Independent Director
111.61K
+79.22%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Recursion Pharmaceuticals Inc?
Los cinco principales accionistas de Recursion Pharmaceuticals Inc son: Dr. Dean Y. Li, M.D., Ph.D.
¿Cuántas instituciones poseen acciones de Recursion Pharmaceuticals Inc (RXRX)?
A fecha de 2026Q1, 721 instituciones poseen acciones de Recursion Pharmaceuticals Inc, con un valor de mercado combinado de aproximadamente 388.34M, lo que representa el 74.06% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 46554673.00.